This role is in line with missense gain-of-function mutations in p53, which lead to aberrant transcriptional activation of chromatin regulators such as MLL2, resulting in elevated histone methylation and acetylation genome-wide, favoring cancer development (Zhu et al. 2015). This evidence concerns the gene TP53 and cancer.